glp-1 semaglutide and tirzepatide Troubling Findings in Study of Compounders Semaglutide vs Tirzepatide 💉⚖️, Both

Clinical studies show that lower doses of GLP-1 agonists are highly effective at reducing hemoglobin A1c (which indicates the average blood sugar level over the past 2-3 months), improving insulin sensitivity, and directly addressing the metabolic dysregulation often associated with estrogen decline and perimenopausal weight gain, helping to stabilize energy levels and reduce fat-storage signaling

Median t max,SNAC,SS was 0.50 h in both treatment groups of healthy subjects and 1.43 h in subjects with T2D

The focus is no longer only on manufacturers producing unregistered medicines

Trust and Transparency Hims & Hers scores well on transparency, access, and flexibility

Victoza 2-Pak (liraglutide, from Novo Nordisk), once daily injection, approved 2010